Femasys secures first European order for FemBloc in Spain, approximately $400,000

FEMASYS INC

First commercial European order for FemBloc permanent birth control valued at ~$400,000 USD.
Distribution partners in Spain: Comercial Medico Quirúrgica and Durgalab.
FemBloc is a non-surgical polymer that degrades to form scar tissue for permanent occlusion.
Company focused on scaling production to meet anticipated European demand.
Spain is the first country globally to offer FemBloc outside the US.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.